OTC · Medical - Devices

Cochlear Limited (CHEOF) Stock

$78.94 -6.84% OTC: CHEOF Healthcare

Cochlear Limited is an Australian enterprise, established in Sydney in 1981, that specializes in advanced implantable hearing technology. This global company develops and distributes a range of auditory solutions for both pediatric and adult populations worldwide.

Valuation

MetricValue
Price$78.94
Market Cap$5.16B
P/E Ratio21.25
P/B Ratio3.79
P/S Ratio3.11
EPS (TTM)$3.71
52-Week High$207.71
52-Week Low$64.39
Dividend Yield3.83%

Financials & Margins

MetricValue
ROE17.76%
ROA12.36%
ROCE21.12%
Gross Margin73.03%
Operating Margin19.98%
Net Margin14.62%
Debt/Equity0.22
Current Ratio2.46

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.5B$1.6B$1.9B$2.2B$2.3B
Operating Profit$370.0M$402.0M$390.0M$475.0M$406.0M
Net Profit$327.0M$289.0M$301.0M$357.0M$389.0M
EPS$4.93$4.40$4.56$5.43$5.93
Op Margin24.7%24.4%20.1%21.3%17.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.4B$2.5B$2.6B$2.7B$2.8B
Total Liabilities$737.0M$779.0M$820.0M$905.0M$875.0M
Cash$610.0M$629.0M$556.0M$514.0M$276.0M
Borrowings$264.0M$254.0M$202.0M$244.0M$236.0M

Latest News

Cochlear introduces the new Osia® 3 Sound Processor PR Newswire · Jul 13, 2026 Don't Miss the Moments That Matter This Summer: Hearing Experts and Cochlear Encourage People to Check Their Hearing Health PR Newswire · Jun 26, 2026 [Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · Jun 17, 2026 Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants PR Newswire · May 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$271.0M$377.0M$362.0M$389.0M$238.0M
Investing Cash Flow$201.0M$-310.0M$-297.0M$-195.0M$-218.0M
Financing Cash Flow$-20.0M$-26.0M$-72.0M$-78.0M$-89.0M
Net Cash Flow$45.0M$20.0M$-74.0M$-42.0M$-238.0M
Free Cash Flow$199.0M$299.0M$267.0M$299.0M$135.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-3.24
EV / EBITDA13.36
FCF Yield2.74%
Quick Ratio1.44
Interest Coverage40.69
Return 1Y-56.10%
Return 3Y-42.92%
Return 5Y—

Ownership

Insiders Held0.64%
Institutions Held64.40%
Institutions Float Held64.81%
Institutional HolderSharesReport Date
Pacer Advisors, Inc.5252026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Cochlear Limited

Cochlear Limited is an Australian enterprise, established in Sydney in 1981, that specializes in advanced implantable hearing technology. This global company develops and distributes a range of auditory solutions for both pediatric and adult populations worldwide. Its product lineup includes cochlear implant devices, upgrades for sound processors, bone conduction systems, and a variety of associated accessories.

Cochlear Limited is headquartered in AU.

Cochlear Limited (CHEOF) stock trades at $78.94 with a market capitalization of $5.16B. The stock is valued at a price-to-earnings (P/E) ratio of 21.25, price-to-book of 3.79, price-to-sales of 3.11. Over the past 52 weeks the stock has ranged between $64.39 and $207.71, and currently trades 62.0% below its 52-week high. It pays a dividend yielding 3.83%.

On profitability, Cochlear Limited generates a return on equity (ROE) of 17.76%, above the typical market average, return on capital employed of 21.12%, an operating margin of 19.98%, a net profit margin of 14.62%.

Official website: www.cochlear.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides